⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
BSH-Active Bifidobacterium (F1-7 / F1-3-2)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-01 — Precision Microbiota Interventions for Senoreduction Trial: 2026 — Registered randomized crossover trial testing GRAS microbiota interventions on immune-senescence biomarkers in HIV + alcohol users adds a human senoreduction probe to the broader microbiota-intervention literature that includes BSH-active strains, but the specific strains tested are not F1-7/F1-3-2 and no readout exists yet. [human-rct] (novelty: 3)
- 2026-07-21 — β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.: cross-connection with nad-precursors: NMN’s benefit depended on raising gut microbial bile salt hydrolase (BSH) activity and lowering conjugated bile acids, overlapping mechanistically with BSH-active Bifidobacterium strains that act through the same bile-acid deconjugation step. (novelty: 3)
- 2026-08-25 — A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan: 2026 Nature news report on a ‘geroprotective probiotic and its functional metabolite’ counteracting inflammaging situates BSH-active Bifidobacterium work within a broader probiotic-plus-postbiotic framing, but the news item cites no new primary data on F1-7/F1-3-2 specifically. [expert-opinion] (novelty: 3)
- 2026-07-17 — Kimchi ProbioticWikim0187 Attenuates Age-Related Muscle Loss: Association with Gut Microbiota Remodeling in Mice.: cross-connection with kimchi-probiotic-wikim0187: Both are aged/atrophy mouse models showing that a single probiotic strain improves sarcopenia endpoints alongside gut microbiota shifts, converging on the gut–muscle axis but via distinct proposed mechanisms (Akt/atrogene suppression vs. bile-acid–FXR–FGF15 signaling). (novelty: 3)
- 2026-07-28 — Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15 axis and its functional fermented milk preparation.: Preclinical mouse study: BSH-active Bifidobacterium animalis F1-7 and F1-3-2 (and a fermented milk preparation) reversed dexamethasone-induced sarcopenia, remodeled the bile acid pool via BSH deconjugation, and activated intestinal FXR–FGF15 signaling (FGFR4/KLB) to reduce muscle protein degradation. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Precision Microbiota Interventions for Senoreduction Trial
01-oct-2026
novelty 3
per-area 3
strengthens
A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan
25-aug-2026
novelty 3
per-area 3
strengthens
Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15 axis and its functional fermented milk preparation.
28-jul-2026
novelty 3
per-area 3
strengthens
Kimchi ProbioticWikim0187 Attenuates Age-Related Muscle Loss: Association with Gut Microbiota Remodeling in Mice.
17-jul-2026
novelty 3
per-area 2
mentions
Effects and mechanisms of lifespan extension and healthspan promotion induced by() A21041.
10-jul-2026
novelty 2
per-area 2
mentions